Center for Novel and Exploratory Clinical Trials, Yokohama City University, Kanagawa, Japan.
Department of Family Medicine and Community Health, Duke University, Durham, North Carolina, USA.
Am J Hypertens. 2021 Apr 2;34(3):250-257. doi: 10.1093/ajh/hpab005.
Cardiovascular disease (CVD) mortality has declined markedly over the past several decades among middle-age and older adults in the United States. However, young adults (18-39 years of age) have had a lower rate of decline in CVD mortality. This trend may be related to the prevalence of high blood pressure (BP) having increased among young US adults. Additionally, awareness, treatment, and control of hypertension are low among US adults between 20 and 39 years of age. Many young adults and healthcare providers may not be aware of the impact of high BP during young adulthood on their later life, the associations of BP patterns with adverse outcomes later in life, and benefit-to-harm ratios of pharmacological treatment. This review provides a synthesis of the related resources available in the literature to better understand BP-related CVD risk among young adults and better identify BP patterns and levels during young adulthood that are associated with CVD events later in life, and lastly, to clarify future challenges in BP management for young adults.
心血管疾病 (CVD) 的死亡率在过去几十年中在美国的中年和老年人中显著下降。然而，年轻成年人 (18-39 岁) 的 CVD 死亡率下降速度较慢。这种趋势可能与美国年轻成年人中高血压 (BP) 的患病率增加有关。此外，20 至 39 岁的美国成年人中高血压的知晓率、治疗率和控制率都较低。许多年轻成年人和医疗保健提供者可能没有意识到年轻时的高血压对他们以后生活的影响，血压模式与以后生活中不良结局的关系，以及药物治疗的获益-危害比。这篇综述综合了相关文献中的可用资源，以更好地了解年轻人的 BP 相关 CVD 风险，并更好地确定与以后生活中的 CVD 事件相关的年轻人的 BP 模式和水平，最后，阐明年轻人 BP 管理的未来挑战。
